Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial.

Name: Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial.
Author: Rosenthal, Seth A

Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial. — المؤلف: Rosenthal, Seth A — Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20200408

المؤلف: Rosenthal, Seth A
النشر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20200408
الوصف: 1159-1168 p.
الموضوعات: Aged؛ Androgen Antagonists؛ Antineoplastic Combined Chemotherapy Protocols؛ Chemoradiotherapy؛ Docetaxel؛ Humans؛ Male؛ Middle Aged